PCL Microspheres Encapsulating LNG + EE

• User: Female
• Hormonal: Hormonal
• Delivery type:
  • Injectable
• Intended Duration:
  • Undetermined
• Development Stage: Discovery & Early Development
• Developer(s)/researcher(s): Vel's College of Pharmacy, University of Connecticut

Details

• API: Levonorgestrel, Ethinyl Estradiol
• Target: Estrogen Receptor, Progesterone Receptor, Androgen Receptor
• Mechanism of Action:
  • Ovulation Inhibition
  • Cervical Mucus Changes
  • Endometrial Changes
• Inactive Materials: PCL, PLGA (Not Scientifically Evaluated)
• Regimen: Undetermined
• MPT: Not Potential MPT

Product Status

Publications